CCPE-CFPCCCPE-CFPC
  • Home
  • Memberships
    • Corporate Membership
  • Take A Course
    • CCPE Courses
    • Custom Courses
    • How to Register for CCPE Courses
    • Study Tools & Resources
    • About Exams
    • Our Awards
  • About Us
    • About Us
    • Our History
    • Our Team
    • Contact Us
  • My CCPE
    • Login
    • Get Help Using MyCCPE
  • EN
    • FR

    CHE, Regulatory & Medical

    • Home
    • All courses
    • CHE, Regulatory & Medical
    • Understanding Market Access Submissions: Public Payers Series for Canada (excluding Quebec)
    Training & HRUnderstanding Market Access Submissions: Public Payers Series for Canada (excluding Quebec)
    • SECTION 1: INTRODUCTION 1

      • Lecture1.1
        Review, Approval and Reimbursement Process
    • SECTION 2: OVERVIEW OF THE CANADIAN MARKET ACCESS LANDSCAPE 2

      MODULE 1: Key Stakeholders in Market Access

      • Lecture2.1
        Chapter 1: Roles and Responsibilities of Payer Stakeholders
      • Lecture2.2
        Chapter 2: Value Proposition: Public Payers vs Prescribers
    • SECTION 2 (contd.): OVERVIEW OF THE CANADIAN MARKET ACCESS LANDSCAPE 3

      Module 2: Overview of the Drug Reimbursement Review Process in Canada

      • Lecture3.1
        Chapter 1: Review of the Overall Reimbursement Process
      • Lecture3.2
        Chapter 2. CDR Review Process
      • Lecture3.3
        Chapter 3: pCODR Review Process
    • SECTION 3: PUBLIC PAYER SUBMISSIONS FOR BRAND DRUG PRODUCTS 3

      MODULE 1: CDR Submission Requirements

      • Lecture4.1
        Chapter 1: Category 1 CDR Submission Requirements
      • Lecture4.2
        Chapter 2: Category 2 CDR Submission Requirements
      • Lecture4.3
        Chapter 3: Additional Information
    • SECTION 3 (contd.): PUBLIC PAYER SUBMISSIONS FOR BRAND DRUG PRODUCTS 2

      MODULE 2: pCODR Submission Requirements

      • Lecture5.1
        Chapter 1: Post-NOC or Post-NOC/c Submission Requirements
      • Lecture5.2
        Chapter 2: Pre-NOC or Pre-NOC/c Submission Requirements
    • SECTION 3 (contd.): PUBLIC PAYER SUBMISSIONS FOR BRAND DRUG PRODUCTS 5

      MODULE 3: Provincial Submission Process

      • Lecture6.1
        Chapter 1: Ontario
      • Lecture6.2
        Chapter 2: British Columbia
      • Lecture6.3
        Chapter 3: Alberta
      • Lecture6.4
        Chapter 4: Atlantic Provinces
      • Lecture6.5
        Chapter 5: Health Canada’s Non-Insured Health Benefits Drug Plan (NIHB)
      This content is protected, please login and enroll course to view this content!
      Next Chapter 1: Roles and Responsibilities of Payer Stakeholders

      Leave A Reply Cancel reply

      Your email address will not be published. Required fields are marked *

      If you're interested in Therapeutic Area courses: Click Here
      logo-CCPE

      Toll Free: 1-888-333-8362

      Fax: 514-333-1119

      info@ccpe-cfpc.org

      3333 de la Côte-Vertu Blvd.
      Suite 350, St-Laurent, QC,
      Canada H4R 2N1

      Organization

      • About Us
      • Contact
      • Our Team

      Links

      • Our Courses
      • MyCCPE

      Support

      • Get Help Using MyCCPE
      • How to Register for CCPE Courses
      • Study Tools & Resources

      © 1997-2019 CCPE-CFPC

      • Privacy Policy
      • Hyperlink Policy